This suggests that the P161S mutation may lead to a shortened systole duration, potentially contributing to hypertrophic cardiomyopathy, as observed in MYBPC3 knockout mouse hearts [12,46,71,72]. This evidence concerns the gene MYBPC3 and hypertrophic cardiomyopathy.